Nagmani Kumar

Nagmani Kumar

Active Director Director DIN 07148119
DIN 07148119 First appointment Jun 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Nagmani Kumar

Data last updated:

Nagmani Kumar is a Director at Amazeen Pharmaceuticals Private Limited (since 2015). The company operates in Chemicals. Amazeen Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (FY 2024).

DIN 07148119
Primary Designation Director
Industry Chemicals
First Appointment 01 Jun 2015
Oldest Company Age 11 yrs
Largest company Amazeen Pharmaceuticals Private Limited · ₹1.03 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20152015₹1.03 Cr (FY 2024)Active

Board colleagues of Nagmani Kumar

NameDINCompanyDesignation
Digamber Sah03525818Amazeen Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amazeen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nagmani Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagmani Kumar

Nagmani Kumar currently holds 1 directorship: Amazeen Pharmaceuticals Private Limited (Director, since 01 Jun 2015, revenue ₹1.03 Cr (FY 2024)).

Nagmani Kumar was first appointed on 01 Jun 2015 as Director at Amazeen Pharmaceuticals Private Limited.

The current boards of Nagmani Kumar's companies include Digamber Sah (Amazeen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available